| JXHL1900161 | Abemaciclib | abemaciclib | Active ingredient | Chemical Drugs(5.1) | Import Drug Application | 2019-07-17 | 美国礼来亚洲公司上海代表处 | Shanghai Representative Office of Eli Lilly Asia;Eli Lilly Nederland BV | In Review | 2019-07-16 | view |
| JXHL1900163 | Abemaciclib | abemaciclib | Active ingredient | Chemical Drugs(5.1) | Import Drug Application | 2019-07-17 | 美国礼来亚洲公司上海代表处 | Shanghai Representative Office of Eli Lilly Asia;Eli Lilly Nederland BV | In Review | 2019-07-16 | view |
| JXHL1900162 | Abemaciclib | abemaciclib | Active ingredient | Chemical Drugs(5.1) | Import Drug Application | 2019-07-17 | 美国礼来亚洲公司上海代表处 | Shanghai Representative Office of Eli Lilly Asia;Eli Lilly Nederland BV | In Review | 2019-07-16 | view |
| JXHS1900144 | Abemaciclib片 | abemaciclib | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2019-11-14 | 美国礼来亚洲公司上海代表处 | Shanghai Representative Office of Eli Lilly Asia;Eli Lilly Nederland BV;Lilly Del Caribe Inc | Certificate Issued | 2021-01-05 | view |
| JXHS1900146 | Abemaciclib片 | abemaciclib | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2019-11-14 | 美国礼来亚洲公司上海代表处 | Shanghai Representative Office of Eli Lilly Asia;Eli Lilly Nederland BV;Lilly Del Caribe Inc | Certificate Issued | 2021-01-05 | view |
| JXHS1900145 | Abemaciclib片 | abemaciclib | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2019-11-14 | 美国礼来亚洲公司上海代表处 | Shanghai Representative Office of Eli Lilly Asia;Eli Lilly Nederland BV;Lilly Del Caribe Inc | Certificate Issued | 2021-01-05 | view |
| JXHL1600075 | AZD3293(LY3314814)薄膜包衣片 | lanabecestat | Tablet | Chemical Drugs(1) | Import Drug Application | 2016-08-05 | 美国礼来亚洲公司上海代表处 | Shanghai Representative Office of Eli Lilly Asia;Eli Lilly & Company | Certificate Issued | 2017-03-17 | view |
| JXHL1600076 | AZD3293(LY3314814)薄膜包衣片 | lanabecestat | Tablet | Chemical Drugs(1) | Import Drug Application | 2016-08-05 | 美国礼来亚洲公司上海代表处 | Shanghai Representative Office of Eli Lilly Asia;Eli Lilly & Company | Certificate Issued | 2017-03-17 | view |
| JYSB2000072 | Galcanezumab注射液 | galcanezumab | Injection | Biological Products | Supplementary Application | 2020-03-21 | 美国礼来亚洲公司上海代表处 | Shanghai Representative Office of Eli Lilly Asia;Eli Lilly & Company | In Review | 2020-03-19 | view |
| JXSL1800019 | Galcanezumab注射液 | galcanezumab | Injection | Biological Products | Import Drug Application | 2018-07-26 | 美国礼来亚洲公司上海代表处 | Shanghai Representative Office of Eli Lilly Asia;Eli Lilly & Company | Certificate Issued | 2018-11-08 | view |
| JXSS1900010 | Ixekizumab注射液 | ixekizumab | Injection | Biological Products | Import Drug Application | 2019-03-01 | 美国礼来亚洲公司上海代表处 | Shanghai Representative Office of Eli Lilly Asia;Eli Lilly & Company | Certificate Issued | 2019-09-03 | view |
| JXHL1900248 | LOXO-292 | Selpercatinib | Active ingredient | Chemical Drugs(1) | Import Drug Application | 2019-09-26 | 美国礼来亚洲公司上海代表处 | Shanghai Representative Office of Eli Lilly Asia;Eli Lilly & Company | In Review | 2019-09-25 | view |
| JYHB2000961 | LOXO-292 | Selpercatinib | Active ingredient | Chemical Drugs(1) | Supplementary Application | 2020-07-03 | 美国礼来亚洲公司上海代表处 | Shanghai Representative Office of Eli Lilly Asia;Quotient Sciences Philadelphia LLC;Eli Lilly & Company | In Review | 2020-07-02 | view |
| JXHL1900251 | LOXO-292 | Selpercatinib | Active ingredient | Chemical Drugs(1) | Import Drug Application | 2019-10-16 | 美国礼来亚洲公司上海代表处 | Shanghai Representative Office of Eli Lilly Asia;Eli Lilly & Company | In Review | 2019-10-14 | view |
| JXHL1900247 | LOXO-292 | Selpercatinib | Active ingredient | Chemical Drugs(1) | Import Drug Application | 2019-09-26 | 美国礼来亚洲公司上海代表处 | Shanghai Representative Office of Eli Lilly Asia;Eli Lilly & Company | In Review | 2019-09-25 | view |
| JYHB2000960 | LOXO-292 | Selpercatinib | Active ingredient | Chemical Drugs(1) | Supplementary Application | 2020-07-03 | 美国礼来亚洲公司上海代表处 | Shanghai Representative Office of Eli Lilly Asia;Quotient Sciences Philadelphia LLC;Eli Lilly & Company | In Review | 2020-07-02 | view |
| JXHL1900250 | LOXO-292 | Selpercatinib | Active ingredient | Chemical Drugs(1) | Import Drug Application | 2019-10-16 | 美国礼来亚洲公司上海代表处 | Shanghai Representative Office of Eli Lilly Asia;Eli Lilly & Company | In Review | 2019-10-14 | view |
| JXHL1900246 | LOXO-292 | Selpercatinib | Active ingredient | Chemical Drugs(1) | Import Drug Application | 2019-09-26 | 美国礼来亚洲公司上海代表处 | Shanghai Representative Office of Eli Lilly Asia;Eli Lilly & Company | In Review | 2019-09-25 | view |
| JXHL1900249 | LOXO-292 | Selpercatinib | Active ingredient | Chemical Drugs(1) | Import Drug Application | 2019-09-26 | 美国礼来亚洲公司上海代表处 | Shanghai Representative Office of Eli Lilly Asia;Eli Lilly & Company | In Review | 2019-09-25 | view |
| JXSL0900073 | LY2062430注射液 | solanezumab | Injection | Biological Products | Import Drug Application | 2009-10-21 | 美国礼来亚洲公司上海代表处 | Shanghai Representative Office of Eli Lilly Asia;Eli Lilly & Company | Certificate Issued | 2011-05-12 | view |
